Lion Point Capital »

Bridgebio Pharma shares owned by Lion Point Capital

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 49k 25.33

More positions owned by Lion Point Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Ardelyx (ARDX)
Insmed Com Par $.01 (INSM)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Milestone Pharmaceuticals (MIST)
Geron Corporation (GERN)
Marinus Pharmaceuticals Com New (MRNS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Mirum Pharmaceuticals Put Option (MIRM)
Syndax Pharmaceuticals (SNDX)
Bridgebio Pharma (BBIO)
Avadel Pharmaceuticals Com Shs (AVDL)
Neurocrine Biosciences (NBIX)
Fennec Pharmaceuticals (FENC)
Mineralys Therapeutics (MLYS)

View all positions for Lion Point Capital

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
Aisling Capital Management
State Street Corporation
Susquehanna International
Laurion Capital Management
Henderson Group
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Alliancebernstein
Goldman Sachs Group
Cormorant Asset Management

View all funds holding Bridgebio Pharma